Search research articles
Contact Us
Filters
Showing results (151-160 of 293) with videos related to
Page
of 30
Sort By:
Advanced Drug Delivery Reviews
|
January 13, 2009
ABCG2: a perspective
Robert W Robey, Kenneth K K To, Orsolya Polgar, et al.
Molecular Cancer Therapeutics
|
June 19, 2007
Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure
Robert W Robey, Suneet Shukla, Kenneth Steadman, et al.
Clinical Journal of Oncology Nursing
|
March 31, 2012
Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma
Robin Frye, Mary Myers, Karen C Axelrod, et al.
Seminars in Oncology
|
August 1, 2022
Assessing Outcomes in NSCLC: Radiomic analysis, kinetic analysis and circulating tumor DNA
Ashray Maniar, Alexander Z Wei, Laurent Dercle, et al.
Nature Reviews. Cancer
|
April 13, 2018
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W Robey, Kristen M Pluchino, Matthew D Hall, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 13, 2004
ABCG2 mediates differential resistance to SN-38 (7-ethyl-10-hydroxycamptothecin) and homocamptothecins
Susan E Bates, Wilma Y Medina-Pérez, Glenda Kohlhagen, et al.
Cancer Journal (Sudbury, Mass.)
|
October 15, 2009
Other paradigms: growth rate constants and tumor burden determined using computed tomography data correlate strongly with the overall survival of patients with renal cell carcinoma
Wilfred D Stein, Hui Huang, Michael Menefee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2017
Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma"
Erkut Borazanci, Chi V Dang, Robert W Robey, et al.
Cell Cycle (Georgetown, Tex.)
|
April 21, 2010
Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells
Jyoti Panicker, Zhijie Li, Christine McMahon, et al.
Seminars in Oncology
|
June 5, 2021
Positive attitudes toward clinical trials among military veterans leaves unanswered questions about poor trial accrual
Grace Clarke Hillyer, Yeun-Hee Anna Park, Ta-Chueh Hsu Rosenberg, et al.
Page
of 30
Search research articles
Search
Showing results (151-160 of 293) with videos related to
Sort By:
Page
of 30
Advanced Drug Delivery Reviews
|
January 13, 2009
ABCG2: a perspective
Robert W Robey, Kenneth K K To, Orsolya Polgar, et al.
Molecular Cancer Therapeutics
|
June 19, 2007
Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure
Robert W Robey, Suneet Shukla, Kenneth Steadman, et al.
Clinical Journal of Oncology Nursing
|
March 31, 2012
Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma
Robin Frye, Mary Myers, Karen C Axelrod, et al.
Seminars in Oncology
|
August 1, 2022
Assessing Outcomes in NSCLC: Radiomic analysis, kinetic analysis and circulating tumor DNA
Ashray Maniar, Alexander Z Wei, Laurent Dercle, et al.
Nature Reviews. Cancer
|
April 13, 2018
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W Robey, Kristen M Pluchino, Matthew D Hall, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 13, 2004
ABCG2 mediates differential resistance to SN-38 (7-ethyl-10-hydroxycamptothecin) and homocamptothecins
Susan E Bates, Wilma Y Medina-Pérez, Glenda Kohlhagen, et al.
Cancer Journal (Sudbury, Mass.)
|
October 15, 2009
Other paradigms: growth rate constants and tumor burden determined using computed tomography data correlate strongly with the overall survival of patients with renal cell carcinoma
Wilfred D Stein, Hui Huang, Michael Menefee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2017
Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma"
Erkut Borazanci, Chi V Dang, Robert W Robey, et al.
Cell Cycle (Georgetown, Tex.)
|
April 21, 2010
Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells
Jyoti Panicker, Zhijie Li, Christine McMahon, et al.
Seminars in Oncology
|
June 5, 2021
Positive attitudes toward clinical trials among military veterans leaves unanswered questions about poor trial accrual
Grace Clarke Hillyer, Yeun-Hee Anna Park, Ta-Chueh Hsu Rosenberg, et al.
Page
of 30